We are collecting your personal data in order to log your interest in attending ESCRS Satellite Meetings. To view our Privacy Policy click here.

Email Address
(this will be your username)
Full Name
Password Confirm Password
Country
EuroTimes Satellite Programme

Thursday 05 September | 13:00 - 14:00

Lunchtime Symposia

Thursday 05 September | 13:00 - 14:00

F. Behar-Cohen France

Unravelling the inflammation pathway

A. García-Layana Spain

Seeking consensus in DME management: findings from Spain

L. Kodjikian France

Key questions for managing DME in daily practice

H. Selen Kanar Turkey

Switch on, switch off: case series

Panelists:

A. Loewenstein Israel

B. Kuppermann US

F. Behar-Cohen France

A. García-Layana Spain

L. Kodjikian France

H. Selen Kanar Turkey

Discussion and Q&A


Location: Amphitheatre Bleu

Transforming DME Clinical Practice

Moderator(s): A. Loewenstein Israel B. Kuppermann US

Thursday 05 September | 13:00 - 14:00

P. Keane UK

Use of swept source OCT in challenging cases of central serous chorioretinopathy

C. Hoyng Netherlands

Morphological and topographical appearance of microaneurysms on swept-source OCTA

V. Papastefanou UK

Diabetic Retinopathy & Swept Source OCTAngio

A. Gaudric France

Patterns of choroidal thickness in healthy choroid: where pachychoroid does start?


Location: Amphitheatre Havane

Clinical Applications of Swept Source OCT & Angiography

Moderator(s): P. Keane UK

Thursday 05 September | 13:00 - 14:00

J. Eells USA

Photobiomodulation for the treatment of retinal and optic nerve disease

K. Valter Australia

From bench to bedside – photobiomodulation in preclinical studies (an update)

M. Munk Switzerland

LIGHTSITE I: clinical analysis of the safety and efficacy of photobiomodulation in subjects with dry age-related macular degeneration

B. Burton UK

LIGHTSITE II: insights from the ongoing multi-center european clinical trial


Location: Room 241

Photobiomodulation: An Innovative, Mitochondria-targeted Therapy for Dry AMD and Other Ocular Diseases (An Update)

Moderator(s): J. Eells USA M. Munk Switzerland

Thursday 05 September | 13:00 - 14:00

B. Bodaghi France

Non-infectious uveitis affecting the posterior segment of the eye

M. Cordero Spain

NIU-PS: the unmet patient need

C. Pavesio UK

The 001 study: ILUVIEN for the prevention of relapse in recurrent NIU-PS

R. Khoramnia Germany

ILUVIEN real world data: experience from clinical practice

Q. Nguyen USA

Lessons learned and patient pathways in NIU-PS / closing remarks


Location: Room 252

ILUVIEN for the Prevention of Relapse in Recurrent Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Moderator(s): B. Bodaghi France Q. Nguyen USA

Friday 06 September | 9:45 - 10:45

Morning Symposia

Friday 06 September | 9:45 - 10:45

Location: Amphitheatre Bleu

Keeping a Step Ahead of the Disease: Proactive Treatment for nAMD

Moderator(s): L. Kodjikian France

Friday 06 September | 9:45 - 10:45


Location: Salle Maillot

A New Vision in Retinal Gene Therapy: from Clinical Trials to Clinical Practice

Moderator(s): B. Leroy Belgium

Friday 06 September | 9:45 - 10:45

C. Orduna Spain

Experiences from 1 year navigated microsecond pulsing laser treatments in DME

N-A. Striebe Germany

Navigated microsecond pulsing treatment for central serous chorioretinopathy. A 100 cases review.

E. Di Carlo Germany

Short term efficacy and safety of navigated microsecond pulsing laser treatment in patients affected by macular edema after BRVO

J. Chhablani USA

Feasibility and study results of navigated microsecond pulsing peripheral laser treatment in diabetic retinopathy


Location: Room 251

Seeing the Invisible - Transparent Subthreshold Treatment with Navigated Microsecond Pulsing Laser

Moderator(s): G. Staurenghi Italy

Friday 06 September | 13:00 - 14:00

Lunchtime Symposia

Friday 06 September | 13:00 - 14:00


Location: Salle Maillot

Ranibizumab in Retinal Diseases

Moderator(s): R. Tadayoni France

Friday 06 September | 13:00 - 14:00

Location: Amphitheatre Bleu

Emerging Evidence: Molecular Properties and Patient Outcomes

Moderator(s): F. Behar-Cohen France

Friday 06 September | 13:00 - 14:00

A. Augustin Germany

Inflammatory response and cytokines in DME

P. Udaondo Spain

Prognostic and predictive biomarkers: research meets clinical practice

F. Bandello Italy

Switch reality: preventing recurrence, preserving vision


Location: Room 252

Breaking the Cycle of Recurrence in DME: Where Research Meets Clinical Practice

Moderator(s): L. Kodjikian France

Friday 06 September | 13:00 - 14:00

S. Sadda USA

Variability of the normal peripheral choroidal circulation

P. Stanga UK

International classification and guidelines for widefield imaging

T. Peto UK

Deep learning and artificial intelligence for diagnosing retinal disease


Location: Amphitheatre Havane

Take Another Look: Uncovering New Advances and Future Applications of Ultra-widefield

Moderator(s): T. Peto UK

Friday 06 September | 13:00 - 14:00

H. Augustin Germany

Spotlight on the angiopoietin pathway

J. Monés Spain

Clinical evidence for the role of Ang-2 in retinal diseases


Location: Room 342

Illuminating the Role of Angiopoietins in Retinal Diseases

Moderator(s): J-F. Korobelnik France

Friday 06 September | 13:00 - 14:00


Location: Room 351

New Mirante Multimodal Imaging and OCT-A Analytics Can Help Breakthrough Tricky Cases of Retinal Disorders

Moderator(s): G. Staurenghi Italy

Friday 06 September | 13:00 - 14:00

R. Carvalho Portugal

The power of Stellaris Elite™ - taking performance further

E. Bali Belgium

Key learnings and surgical pearls with Vitesse™

Bausch + Lomb R&D team

How we’re raising the bar in retina innovation


Location: Room 241

Reimagine your Retina Surgery with Bausch + Lomb

Moderator(s): Y. Le Mer France

Saturday 07 September | 9:45 - 10:45

Morning Symposia

Saturday 07 September | 9:45 - 10:45

R. Tadayoni France

Introduction and opening remarks

K. Al Sabti Kuwait

Go beyond 3D visualization

F. Devin France

Complex and VR surgical cases using the advanced features of the Constellation® Vision System

S. Rizzo Italy

Speed, flow, stability, access-the new HyperVit™ 20K vitrectomy Probe

M. Mura Saudi Arabia

27+® as go-to technology for challenging vitreoretinal cases

J.A. Pournaras Switzerland

Modern surgical management of vitreoretinal pathologies

N. Bechrakis Germany

Management of intraocular tumors with an advanced surgical system


Location: Room 252

The Vitreoretinal Procedure - Integration, Stability, Speed

Moderator(s): R. Tadayoni France

Saturday 07 September | 9:45 - 10:45

Location: Amphitheatre Bleu

Unsurpassed Vision Gains and Optimized Patient Outcomes in DME

Moderator(s): J-F Korobelnik France

Saturday 07 September | 9:45 - 10:45

A. García-Layana Spain

Welcome and introduction

F. Bandello Italy

Unmet needs in the management of nAMD

L. Kodjikian France

The future of nAMD

M. Stumpp Switzerland

DARPin - a new approach to nAMD

M. De Smet Switzerland

What´s in the pipeline for patients?


Location: Amphitheatre Bordeaux

nAMD Management: Beyond the Horizon

Moderator(s): F. Bandello Italy A. García-Layana Spain

Saturday 07 September | 9:45 - 10:45


Location: Salle Maillot

Applying Advanced Digital Technology in Practice

Moderator(s): N. Bressler USA

Saturday 07 September | 9:45 - 10:45

J. Monés Spain

The role of complement in geographic atrophy

U. Chakravaraty UK

Results from the FILLY phase 2 trial

I. Pearse UK

Evaluation of baseline characteristics on GA lesion progression in the FILLY trial

F.G. Holz Germany

Derby and Oaks phase 3 trials in GA


Location: Room 351

Complement C3 Inhibition in Geographic Atrophy

Moderator(s): F.G. Holz Germany

Saturday 07 September | 13:00 - 14:00

Lunchtime Symposia

Saturday 07 September | 13:00 - 14:00


Location: Amphitheatre Bordeaux

New Horizons in nAMD Treatment

Moderator(s): F.G. Holz Germany

Saturday 07 September | 13:00 - 14:00

P. Stalmans Belgium

First evidence for clinical trial of 27G vs 23G surgery

E. El Rayes Egypt

How innovation is making 27G a reality

C. Mazit France

Management of retinal detachment using 27g and a prospective randomised study comparing 25G vs 27G for the management of ERM and macular holes

F. Nerinckx Belgium

First experience with a new shorter 27G vitrectomy kit


Location: Room 252

Ready for Prime Time: Clinical Evidence of Advances in 27G Surgery

Moderator(s): P. Stalmans Belgium

Saturday 07 September | 13:00 - 14:00

A. García-Layana Spain

A. Minnella Italy

How to manage patients at risk of AMD with STARS questionnaire

A. Tufail UK

Artificial intelligence. Where do we go from here?

C. Creuzot-Garcher France

Diabetic retinopathy and OCT-A

D. Crabb UK

And what do people with AMD see?


Location: Room 351

Innovative Thinking in Retinal Disease

Moderator(s): J. Seddon USA

Saturday 07 September | 13:00 - 14:00

V. Chong UK

How retina lasers are different from each other?

A. Filloy Spain

Fovea-involving DME: reasons for the SubLiminal approach

L. Altay Germany

SubLiminal laser in CCSC management

L. Wu Costa Rica

Why SubLiminal laser should be favored vs PDT for CCSC treatment

V. Chong UK

New treatment perspectives and conclusion


Location: Room 241

Management of Retinal Diseases with SubLiminal Laser Therapy

Moderator(s): V. Chong UK

Saturday 07 September | 13:00 - 14:00

A. Loewenstein Israel

Outcomes in real-world settings and therapeutic advancements

P. Campochiaro USA

Continuous delivery: A future approach to nAMD management


Location: Room 342

Delivering the Future of nAMD Management

Moderator(s): R. Tadayoni France

Saturday 07 September | 13:00 - 14:00

J-F. Korobelnik France

Exploring new boundaries of OCT-A

G. Staurenghi Italy

Next generation of ultra-widefield angiography

G. Lang Germany

Integrated diagnostic imaging maximizing your diagnostic instruments


Location: North 4

Retinal Imaging Advancements

Moderator(s): J-F. Korobelnik France